JMP Securities Reiterates “Market Outperform” Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)
JMP Securities reissued their market outperform rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a report issued on Thursday,Benzinga reports. The firm currently has a $84.00 price target on the stock. A number of other research firms have also recently commented on RYTM. HC Wainwright restated a “buy” rating and issued a […]
JMP Securities reissued their market outperform rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a report issued on Thursday,Benzinga reports. The firm currently has a $84.00 price target on the stock. A number of other research firms have also recently commented on RYTM. HC Wainwright restated a “buy” rating and issued a […]
